TSHA IPOs 9.05M* shares @$20.00: https://finance.yahoo.com/news/taysha-gene-therapies-announces-pricing-110000874.html Taysha Gene Therapies [is] a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations… *Assuming exercise of underwriter’s option.